TGM3 is involved in the transformation of the cell envelope in epidermis and hair follicles, but it is also a tumour suppressor and has been proposed as a progression marker for radio-chemotherapy of head and neck cancers [32, 40]. This evidence concerns the gene TGM3 and neoplasm.